Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has enclosed the schedule of the Analyst/ Institutional Investor Meeting with the Company on 28th May, 2024.
The above information is a part of company’s filings submitted to BSE.